Shefali Sood1, Leonardo Trasande, Shilpi S Mehta-Lee, Sara G Brubaker, Akhgar Ghassabian, Melanie H Jacobson. 1. From the Department of Pediatrics, Division of Environmental Pediatrics, NYU Langone Medical Center, New York, NY, 10016, USA (SS, LT, AG, MHJ); Department of Population Health, NYU Langone Medical Center, New York, NY, 10016, USA (LT, AG); Department of Environmental Medicine, NYU Langone Medical Center, New York, NY, 10016, USA (LT, AG); NYU Wagner School of Public Service, New York, NY, USA (LT); NYU College of Global Public Health, New York, NY, USA (LT); Department of Obstetrics and Gynecology, NYU Langone Medical Center, New York, NY 10016 USA (SSM-L, SGB).
Abstract
OBJECTIVE: To estimate the prevalence of perinatal cannabis use (ie, before and/or during pregnancy); document the frequency, modes, and motivations for use; and identify predictors of perinatal cannabis use. METHODS: Six states in the Pregnancy Risk Assessment Monitoring System, a state-specific, population-based surveillance system, administered a supplemental questionnaire on perinatal cannabis use in 2016-2018. Women with live births were surveyed 2-6 months postpartum about behaviors ≤ 3 months preconception and during pregnancy. Demographic, psychosocial, and behavioral characteristics were examined in relation to perinatal cannabis use using multinomial regression models. Those who: (1) never used cannabis, (2) only used in preconception period, and (3) used in both preconception and prenatal periods were compared. RESULTS: Among 6428 respondents, 379 (5.8%) used cannabis pre-conceptionally only and 466 (4.4%) used in both the preconception and prenatal periods. Among those using prenatally, most reported smoking as their single mode (87.1%), with the two most common reasons being stress (83.8%) and nausea/vomiting (79.2%). Marital status, race/ethnicity, socioeconomic status, parity, and cigarette and alcohol use were significantly associated with perinatal cannabis use. Single (vs partnered) women were more likely to use cannabis prenatally (odds ratio = 2.4, 95% confidence interval: 1.5, 3.9) and non-Hispanic Black (vs White) women were less likely to use prenatally (odds ratio = 0.4, 95% confidence interval: 0.2, 0.8). CONCLUSIONS: Using a population-based sample of US births in six states, several demographic, psychosocial, and behavioral characteristics were identified in relation to perinatal cannabis use. These data are valuable for counseling in prenatal care and investigations of health effects.
OBJECTIVE: To estimate the prevalence of perinatal cannabis use (ie, before and/or during pregnancy); document the frequency, modes, and motivations for use; and identify predictors of perinatal cannabis use. METHODS: Six states in the Pregnancy Risk Assessment Monitoring System, a state-specific, population-based surveillance system, administered a supplemental questionnaire on perinatal cannabis use in 2016-2018. Women with live births were surveyed 2-6 months postpartum about behaviors ≤ 3 months preconception and during pregnancy. Demographic, psychosocial, and behavioral characteristics were examined in relation to perinatal cannabis use using multinomial regression models. Those who: (1) never used cannabis, (2) only used in preconception period, and (3) used in both preconception and prenatal periods were compared. RESULTS: Among 6428 respondents, 379 (5.8%) used cannabis pre-conceptionally only and 466 (4.4%) used in both the preconception and prenatal periods. Among those using prenatally, most reported smoking as their single mode (87.1%), with the two most common reasons being stress (83.8%) and nausea/vomiting (79.2%). Marital status, race/ethnicity, socioeconomic status, parity, and cigarette and alcohol use were significantly associated with perinatal cannabis use. Single (vs partnered) women were more likely to use cannabis prenatally (odds ratio = 2.4, 95% confidence interval: 1.5, 3.9) and non-Hispanic Black (vs White) women were less likely to use prenatally (odds ratio = 0.4, 95% confidence interval: 0.2, 0.8). CONCLUSIONS: Using a population-based sample of US births in six states, several demographic, psychosocial, and behavioral characteristics were identified in relation to perinatal cannabis use. These data are valuable for counseling in prenatal care and investigations of health effects.
Authors: Arpana Agrawal; Cynthia E Rogers; Christina N Lessov-Schlaggar; Ebony B Carter; Shannon N Lenze; Richard A Grucza Journal: JAMA Pediatr Date: 2019-01-01 Impact factor: 16.193
Authors: Holly B Shulman; Denise V D'Angelo; Leslie Harrison; Ruben A Smith; Lee Warner Journal: Am J Public Health Date: 2018-08-23 Impact factor: 9.308
Authors: Judy C Chang; Jill A Tarr; Cynthia L Holland; Natacha M De Genna; Gale A Richardson; Keri L Rodriguez; Jeanelle Sheeder; Kevin L Kraemer; Nancy L Day; Doris Rubio; Marian Jarlenski; Robert M Arnold Journal: Drug Alcohol Depend Date: 2019-01-11 Impact factor: 4.492
Authors: Qiana L Brown; Aaron L Sarvet; Dvora Shmulewitz; Silvia S Martins; Melanie M Wall; Deborah S Hasin Journal: JAMA Date: 2017-01-10 Impact factor: 56.272
Authors: Betsy Dickson; Chanel Mansfield; Maryam Guiahi; Amanda A Allshouse; Laura M Borgelt; Jeanelle Sheeder; Robert M Silver; Torri D Metz Journal: Obstet Gynecol Date: 2018-06 Impact factor: 7.661
Authors: Alicia M Allen; Alesia M Jung; Adam C Alexander; Sharon S Allen; Kenneth D Ward; Mustafa al'Absi Journal: Addiction Date: 2020-03-10 Impact factor: 7.256
Authors: Tali Azenkot; Melanie S Dove; Chuncui Fan; Cindy V Valencia; Elisa K Tong; Eleanor Bimla Schwarz Journal: Matern Child Health J Date: 2022-10-03